Information Request Form

Please enter your message in the form below. Your message will be emailed directly to the contact associated with the press release upon the submission of the form.

Press Release:
NicOx, Bausch + Lomb Glaucoma Candidate BOL 303259 X Meets Primary Endpoint in Phase 2b Study Bausch + Lomb to Pursue Global Phase 3 Development Program
Press Release Date:
03/13/2012 02:48 AM Eastern Time
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)

Information entered into this form will be relayed, solely to the Marketwire client contact that is associated with this release. Your privacy is important to us, and we make sure it is properly protected. Please see our privacy policy for more details.